Serum Myoglobin

1979 ◽  
Vol 139 (6) ◽  
pp. 628 ◽  
Author(s):  
Lawrence J. Kagen
Keyword(s):  
1984 ◽  
Vol 44 (7) ◽  
pp. 649-654 ◽  
Author(s):  
Flemming Pedersen ◽  
SØRen Lind Rasmussen ◽  
Klaus Kolendorf ◽  
Erik Christiansen

1998 ◽  
Vol 28 (6) ◽  
pp. 915
Author(s):  
Jang-Young Kim ◽  
Ju-Yong Lee ◽  
Jong-Won Ha ◽  
Sung-Oh Hwang ◽  
Kum-Soo Park ◽  
...  

2020 ◽  
Author(s):  
Yan Geng ◽  
Yong-sheng Du ◽  
Na Peng ◽  
Ting Yang ◽  
Shi-yu Zhang ◽  
...  

Abstract Purpose: To evaluate the clinical features and outcomes of rhabdomyolysis (RM) in patients with COVID-19. Method: A single center retrospective cohort study of 1,014 consecutive hospitalized patients with confirmed COVID-19 at the Huoshenshan hospital in Wuhan, China, between February 17 and April 12, 2020. Results: The overall incidence of RM was 2.2%. Comparing with patients without RM, patients with RM tended to have a higher risk of deterioration, representing by higher ratio to be admitted to the intensive care unit (ICU) (90.9 % vs 5.3%, P<0.001), and to undergo mechanical ventilation (86.4 % vs 2.7% P<0.001). Compared with patients without RM, patients with RM had laboratory test abnormalities, including indicators of inflammation, coagulation activation and kidney injury. Patients with RM had a higher risk of hospital death (P < 0.001). Cox proportional hazard regression model confirmed that RM indicators, including peak creatine kinase (CK) >1000 IU/L (HR=6.46, 95% CI: 3.02-13.86), peak serum myoglobin (MYO) >1000 ng/mL (HR=9.85, 95% CI: 5.04-19.28) were independent risk factors for in-hospital death. Additionally, patients with COVID-19 that developed RM tended to have a delayed virus clearance.Conclusion: RM might be an important factor contributing to adverse outcomes of patients with COVID-19. Early detection and effective intervention of RM may help reduce deaths of patients with COVID-19.


1996 ◽  
Vol 3 (4) ◽  
pp. 289-292
Author(s):  
Naoyuki Fujimura ◽  
Johji Arakawa ◽  
Naoto Inagaki ◽  
Naoki Tsujiguchi ◽  
Masatoshi Kotaki ◽  
...  

1975 ◽  
Vol 35 (1) ◽  
pp. 171 ◽  
Author(s):  
C.Bevan Stuart ◽  
Fred J. Palmer ◽  
Mr.George W. Nevatt ◽  
John E. Lewis ◽  
Roy V. Jutzy ◽  
...  

2020 ◽  
Vol 185 (Supplement_1) ◽  
pp. 42-49 ◽  
Author(s):  
Harris W Kashtan ◽  
Meryl A Simon ◽  
Carl A Beyer ◽  
Andrew Wishy ◽  
Guillaume L Hoareau ◽  
...  

Abstract Introduction External cooling of ischemic limbs has been shown to have a significant protective benefit for durations up to 4 hours. Materials and Methods It was hypothesized that this benefit could be extended to 8 hours. Six swine were anesthetized and instrumented, then underwent a 25% total blood volume hemorrhage. Animals were randomized to hypothermia or normothermia followed by 8 hours of Zone 3 resuscitative endovascular balloon occlusion of the aorta, then resuscitation with shed blood, warming, and 3 hours of critical care. Physiologic parameters were continuously recorded, and laboratory specimens were obtained at regular intervals. Results There were no significant differences between groups at baseline. There were no significant differences between creatine kinase in the hypothermia group when compared to the normothermia group (median [IQR] = 15,206 U/mL [12,476−19,987] vs 23,027 U/mL [18,745−26,843]); P = 0.13) at the end of the study. Similarly, serum myoglobin was also not significantly different in the hypothermia group after 8 hours (7,345 ng/mL [5,082−10,732] vs 5,126 ng/mL [4,720−5,298]; P = 0.28). No histologic differences were observed in hind limb skeletal muscle. Conclusion While external cooling during prolonged Zone 3 resuscitative endovascular balloon occlusion of the aorta appears to decrease ischemic muscle injury, this benefit appears to be time dependent. As the ischemic time approaches 8 hours, the benefit from hypothermia decreases.


1992 ◽  
Vol 38 (5) ◽  
pp. 789-790 ◽  
Author(s):  
L Vrenna ◽  
A M Castaldo ◽  
P Castaldo ◽  
D Giardiello ◽  
C Di Giacomo ◽  
...  

1994 ◽  
Vol 40 (5) ◽  
pp. 796-802 ◽  
Author(s):  
A H Wu ◽  
I Laios ◽  
S Green ◽  
T G Gornet ◽  
S S Wong ◽  
...  

Abstract We compared four immunoassays for serum and urine myoglobin. Within-run CVs were 5-13%, with biases seen between assays. Myoglobin was stable for 1 month in serum and 12 days in urine when the pH was adjusted to between 8.0 and 9.5. Hemoglobin caused no interference. We assayed 91 pairs of serum and timed urine specimens from 41 patients admitted for acute trauma or rhabdomyolysis. Most were treated with mannitol and alkalinization. Upon initial presentations, 21 patients with either low serum myoglobin concentrations (&lt; 400 micrograms/L) or high myoglobin clearances (&gt; or = 4 mL/min) had normal creatinine clearances and no clinical evidence of renal disease. The remaining 20 had low myoglobin clearances. Seven were in rhabdomyolysis-induced acute renal failure, or subsequently developed this complication. We suggest that low myoglobin clearance may indicate a high risk for developing renal failure or may be an early marker for kidney dysfunction. Low myoglobin clearance may prove useful in indicating failure of prophylactic treatment to clear myoglobin.


Sign in / Sign up

Export Citation Format

Share Document